Published in
Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 14(21), p. 1675-1684, 2020
DOI: 10.1080/14656566.2020.1787380
Links
Tools
Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia
Journal article published in 2020 by
Laura D’Erasmo,
Antonio Gallo 
,
Alessia Di Costanzo,
Eric Bruckert,
Marcello Arca
,
Alessia Di Costanzo,
Eric Bruckert,
Marcello Arca
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 